Syncom Formulations (India) submits reconciliation of share capital audit report

13 Jan 2023 Evaluate
With reference to the compliance of Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018 (Previously known as Regulations 55A of SEBI (Depositories and Participants) Regulations 1996} & Circular No. D&CC/FITTC/CIR-16/2002 dated December 31st 2002 issued by SEBI, Syncom Formulations (India) has submitted Reconciliation of Share Capital Audit Report for the Quarter ended 31st December, 2022. The Reconciliation of Share Capital Audit Report will also be filed in XBRL mode within the stipulated time period.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

12.97 0.02 (0.15%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×